rs778094136
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001358921.2(COQ2):āc.232A>Gā(p.Met78Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000165 in 1,576,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 34)
Exomes š: 0.000015 ( 0 hom. )
Consequence
COQ2
NM_001358921.2 missense
NM_001358921.2 missense
Scores
3
2
13
Clinical Significance
Conservation
PhyloP100: 4.62
Genes affected
COQ2 (HGNC:25223): (coenzyme Q2, polyprenyltransferase) This gene encodes an enzyme that functions in the final steps in the biosynthesis of CoQ (ubiquinone), a redox carrier in the mitochondrial respiratory chain and a lipid-soluble antioxidant. This enzyme, which is part of the coenzyme Q10 pathway, catalyzes the prenylation of parahydroxybenzoate with an all-trans polyprenyl group. Mutations in this gene cause coenzyme Q10 deficiency, a mitochondrial encephalomyopathy, and also COQ2 nephropathy, an inherited form of mitochondriopathy with primary renal involvement. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14514425).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COQ2 | NM_001358921.2 | c.232A>G | p.Met78Val | missense_variant | 1/7 | ENST00000647002.2 | NP_001345850.1 | |
COQ2 | NM_015697.9 | c.382A>G | p.Met128Val | missense_variant | 1/7 | NP_056512.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ2 | ENST00000647002.2 | c.232A>G | p.Met78Val | missense_variant | 1/7 | NM_001358921.2 | ENSP00000495761 | P2 | ||
COQ2 | ENST00000311469.9 | c.382A>G | p.Met128Val | missense_variant | 1/7 | 1 | ENSP00000310873 | A2 | ||
COQ2 | ENST00000311461.7 | c.232A>G | p.Met78Val | missense_variant | 1/7 | 5 | ENSP00000311835 | |||
COQ2 | ENST00000503391.5 | c.232A>G | p.Met78Val | missense_variant, NMD_transcript_variant | 1/7 | 2 | ENSP00000426242 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151932Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
4
AN:
151932
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000495 AC: 9AN: 181648Hom.: 0 AF XY: 0.0000199 AC XY: 2AN XY: 100282
GnomAD3 exomes
AF:
AC:
9
AN:
181648
Hom.:
AF XY:
AC XY:
2
AN XY:
100282
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000154 AC: 22AN: 1424446Hom.: 0 Cov.: 84 AF XY: 0.0000113 AC XY: 8AN XY: 705924
GnomAD4 exome
AF:
AC:
22
AN:
1424446
Hom.:
Cov.:
84
AF XY:
AC XY:
8
AN XY:
705924
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151932Hom.: 0 Cov.: 34 AF XY: 0.0000539 AC XY: 4AN XY: 74212
GnomAD4 genome
AF:
AC:
4
AN:
151932
Hom.:
Cov.:
34
AF XY:
AC XY:
4
AN XY:
74212
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:4Other:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects COQ2 function (PMID: 23758206). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COQ2 protein function. ClinVar contains an entry for this variant (Variation ID: 60536). This missense change has been observed in individual(s) with multiple system atrophy (PMID: 23758206). This variant is present in population databases (rs778094136, gnomAD 0.07%). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 128 of the COQ2 protein (p.Met128Val). - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Coenzyme Q10 deficiency, primary, 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 23, 2022 | Variant summary: COQ2 c.382A>G (p.Met128Val) results in a conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 212966 control chromosomes (gnomAD). c.382A>G has been reported in the literature in at least two homozygous siblings affected with Multiple System Atrophy (Multiple-System Atrophy Research Collaboration_2013). These individuals were also homozygous for p.Val343Ala, which is considered a benign polymorphism (ClinVar:214217). These data indicate that the variant is likely to be associated with disease. Several publications have examined the functional impact of the variant: the variant could not rescue growth in a COQ2-null yeast strain (Multiple-System Atrophy Research Collaboration_2013); COQ2-null yeast expressing the the variant had decreased expression of other Coenzyme Q genes (COQ6, Desbats_2016); COQ2-null yeast had reduced oxygen consumption rate compared to wild-type (Yasuda_2019). Two ClinVar submitters have assessed the variant since 2014: one classified the variant as VUS, and one as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 23, 2021 | The c.382A>G (p.M128V) alteration is located in exon 1 (coding exon 1) of the COQ2 gene. This alteration results from a A to G substitution at nucleotide position 382, causing the methionine (M) at amino acid position 128 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Coenzyme Q10 deficiency, primary, 1;C3714927:Multiple system atrophy 1, susceptibility to Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 04, 2022 | - - |
Multiple system atrophy Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 03, 2014 | - - |
Coenzyme Q10 deficiency Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Pathogenic
D;.;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;D;N
REVEL
Uncertain
Sift
Benign
.;T;T
Sift4G
Benign
.;T;T
Polyphen
0.13
.;.;B
Vest4
0.73, 0.83
MutPred
Loss of glycosylation at P73 (P = 0.0474);.;Loss of glycosylation at P73 (P = 0.0474);
MVP
0.63
MPC
0.18
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at